Business · 23/01/2024Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for In Vivo Radiopharmaceuticals
Summary
The FDA has submitted a proposed collection of information to the Office of Management and Budget for review and clearance, related to regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →